Pure Global

A prospective observational study to assess the utility of comprehensive genomic profiling in patients with non-small cell lung cancer without driver genetic alterations - Trial UMIN000052408

Access comprehensive clinical trial information for UMIN000052408 through Pure Global AI's free database. This phase not specified trial is sponsored by Hamamatsu University School of Medicine and is currently Recruiting. The study focuses on Non-small cell lung cancer.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to University Hospital Medical Information Network data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
UMIN000052408
Recruiting
Trial Details
University Hospital Medical Information Network โ€ข UMIN000052408
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
A prospective observational study to assess the utility of comprehensive genomic profiling in patients with non-small cell lung cancer without driver genetic alterations
A prospective observational study to assess the utility of comprehensive genomic profiling in patients with non-small cell lung cancer without driver genetic alterations identified by multiplex companion diagnostics

Study Focus

Observational

Sponsor & Location

Hamamatsu University School of Medicine

Japan

Timeline & Enrollment

N/A

Oct 10, 2023

N/A

ICD-10 Classifications

Secondary malignant neoplasm of lung
Malignant neoplasm: Lower lobe, bronchus or lung
Malignant neoplasm: Middle lobe, bronchus or lung
Malignant neoplasm: Bronchus or lung, unspecified
Malignant neoplasm of bronchus and lung

Data Source

University Hospital Medical Information Network

UMIN000052408

Non-Device Trial